BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 22212022)

  • 1. Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a.
    Tomášová Z; Hluštík P; Král M; Otruba P; Herzig R; Krobot A; Kaňovský P
    J Neuroimaging; 2013 Jul; 23(3):337-44. PubMed ID: 22212022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke.
    Veverka T; Hluštík P; Tomášová Z; Hok P; Otruba P; Král M; Tüdös Z; Zapletalová J; Herzig R; Krobot A; Kaňovský P
    J Neurol Sci; 2012 Aug; 319(1-2):89-95. PubMed ID: 22687958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
    Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
    J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
    Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P
    J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensorimotor modulation by botulinum toxin A in post-stroke arm spasticity: Passive hand movement.
    Veverka T; Hluštík P; Hok P; Otruba P; Zapletalová J; Tüdös Z; Krobot A; Kaňovský P
    J Neurol Sci; 2016 Mar; 362():14-20. PubMed ID: 26944111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
    J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
    Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
    Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
    Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?
    Hefter H; Jost WH; Reissig A; Zakine B; Bakheit AM; Wissel J
    Int J Rehabil Res; 2012 Sep; 35(3):227-33. PubMed ID: 22555318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
    Hameau S; Bensmail D; Robertson J; Boudarham J; Roche N; Zory R
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):515-23. PubMed ID: 24651151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin modulates cortical maladaptation in post-stroke spasticity.
    Huynh W; Krishnan AV; Lin CS; Vucic S; Katrak P; Hornberger M; Kiernan MC
    Muscle Nerve; 2013 Jul; 48(1):93-9. PubMed ID: 23625819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
    J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K; Morishita T; Hyakutake K; Fukuda H; Shiota E; Sankai Y; Inoue T
    J Neurol Sci; 2017 Feb; 373():182-187. PubMed ID: 28131185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.
    Chen YT; Zhang C; Liu Y; Magat E; Verduzco-Gutierrez M; Francisco GE; Zhou P; Zhang Y; Li S
    Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral weakness following botulinum toxin for poststroke spasticity.
    Thomas AM; Simpson DM
    Muscle Nerve; 2012 Sep; 46(3):443-8. PubMed ID: 22907238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical somatosensory processing after botulinum toxin therapy in post-stroke spasticity.
    Veverka T; Hluštík P; Otruba P; Hok P; Opavský R; Zapletalová J; Kaňovský P
    Medicine (Baltimore); 2021 Jun; 100(25):e26356. PubMed ID: 34160405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
    Bensmail D; Hanschmann A; Wissel J
    J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.